Homology
is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases... Read moreHomology
is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases... Read more
2015
PublicMerged with Q32 Bio Inc.NASDAQFIXX
News
Mar 26, 2024
Pharmaceutical Business Review
Homology: Q32 Bio concludes merger deal with Homology Medicines
Mar 18, 2024
Benzinga
Homology: Homology Medicines Declares Distribution to Common Stockholders
Mar 13, 2024
Marketscreener
Homology: Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb 27, 2024
MarketScreener
Homology: HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
Jan 03, 2024
centralcharts
Press Release: Homology : Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Nov 17, 2023
Acrofan
Homology: HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc.
Nov 17, 2023
Pharmaceutical Business Review
Homology: Q32 Bio to merge with Homology Medicines
Nov 15, 2023
centralcharts
Press Release: Homology : Homology Medicines Reports Third Quarter 2023 Financial Results
Nov 14, 2023
Yahoo
Homology: Homology Medicines: Q3 Earnings Snapshot
Aug 16, 2023
centralcharts
Press Release: Homology : SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Lawsuit Against Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) and Encourages Long-Term ACAD Investors to Contact the Firm
Homology Competitors
1
2
3
4
5
6
7
8
9
10